Matriks Biotek®，生物药物测试SHIKARI®ELISA Kit。人源化重组单克隆抗体，作为药物在某些疾病中的应用，引发了每个个体治疗者的有效性问题。监测药物水平和抗体在重组抗体和/或人源抗体缺失时起的作用。(即，以确定治疗的继续，调整剂量，提供一个依据切换到另一种药剂或另一类生物药剂)。
| Drug | Referance Code | Description | Product |
| INFLIXIMAB | TR-Q-INFLIXIv2 | Free drug | SHIKARI® Q-INFLIXI |
| TR-ATIv5 | Qualitative Screening ADA | SHIKARI® Q-ATI | |
| TR-ATIv6 | Quantitative w/confirmation | SHIKARI® Q-ATI | |
| TR-ATIv8 | Total & Free Semi-Quantitative (Drug Tolerant Assay) | SHIKARI® Q-ATI DUO | |
| ADALIMUMAB | TR-ADAv1 | Free drug | SHIKARI® Q-ADA |
| TR-AADAv1 | Qualitative Screening ADA | SHIKARI® S-ATA | |
| TR-AADAv2 | Quantitative w/confirmation | SHIKARI® S-ATA | |
| TR-AADAv4 | Total & Free Semi-Quantitative (Drug Tolerant Assay) | SHIKARI® S-ATA DUO | |
| ETANERCEPT | TR-ETAv2 | Free drug | SHIKARI® Q-ETA |
| TR-AETAv2 | Qualitative Screening ADA | SHIKARI® S-ATE | |
| BEVACIZUMAB | TR-BEVAv2 | Free drug | SHIKARI® Q-BEVA |
| TR-ABEVAv1 | Qualitative Screening ADA | SHIKARI® S-ATB | |
| TR-ABEVAv2 | Quantitative w/confirmation | SHIKARI® S-ATB | |
| RITUXIMAB | TR-RTXv2 | Free drug | SHIKARI® Q-RITUX |
| TR-ARTXv1 | Qualitative Screening ADA | SHIKARI® S-ATR | |
| TR-ARTXv2 | Quantitative w/confirmation | SHIKARI® S-ATR | |
| TRASTUZUMAB | TR-TRASv2 | Free drug | SHIKARI® Q-TRAS |
| TR-ATRASv1 | Qualitative Screening ADA | SHIKARI® S-ATT | |
| TR-ATRASv2 | Quantitative w/confirmation | SHIKARI® S-ATT | |
| GOLIMUMAB | TR-GOLv1 | Free drug | SHIKARI® Q-GOL |
| TR-ATGv1 | Qualitative Screening ADA | SHIKARI® S-ATG | |
| INFLIXIMAB BIOSIMILAR | TR-REMSv1 | Free drug | SHIKARI® Q-REMS |
| TR-AREMSv1 | Qualitative Screening ADA | SHIKARI® S-AIR | |
| TR-AREMSv2 | Quantitative w/confirmation | SHIKARI® S-AIR | |
| TR-AREMSv3 | Total Semi-Quantitative | SHIKARI® S-AIR | |
| CETUXIMAB | TR-CETv1 | Free drug | SHIKARI® Q-CET |
| TR-ATCv1 | Qualitative Screening ADA | SHIKARI® S-ATC | |
| TR-ATCv2 | Quantitative w/confirmation | SHIKARI® S-ATC | |
| DENOSUMAB | TR-QDENv1 | Free drug | SHIKARI® Q-DEN |
| TR-AATDv1 | Qualitative Screening ADA | SHIKARI® S-ATD | |
| OMAZILUMAB | TR-OMAv1 | Free drug | SHIKARI® Q-OMA |
| TR-AATOv1 | Qualitative Screening ADA | SHIKARI® S-ATO | |
| NIVOLUMAB | TR-Q-NIVOv1 | Free drug | SHIKARI® Q-NIV |
| TR-ATNv1 | Qualitative Screening ADA | SHIKARI® S-ATN | |
| PEMBROLIZUMAB | TR-PEMv1 | Free drug | SHIKARI® Q-PEM |
| TR-A-PEMv1 | Qualitative Screening ADA | SHIKARI® S-ATP | |
| IPILIMUMAB | TR-IPIv1 | Free drug | SHIKARI® Q-IPI |
| TR-AIPIv1 | Qualitative Screening ADA | SHIKARI® S-ATI | |
| FILGRASTIM | TR-AFAv1 | Quantitative w/confirmation | SHIKARI® Q-AFA |
| AVELUMAB | TR-Q-AVEv1 | Free drug | SHIKARI® Q-AVE |
| TR-A-AVEv1 | Qualitative Screening ADA | SHIKARI® S-ATAV | |
| RANIBIZUMAB | TR-RANv1 | Free drug | SHIKARI® Q-RAN |
| RAMUCIRUMAB | TR-RAMv1 | Free drug | SHIKARI® Q-RAM |
| TR-ARAMv1 | Qualitative Screening ADA | SHIKARI® S-ATRAM | |
| CERTOLIZUMAB | TR-CERTv1 | Free drug | SHIKARI® Q-CERT |
| VEDOLIZUMAB | TR-Q-VEDOv1 | Free drug | SHIKARI® Q-VEDO |
| TR-ATVv1 | Qualitative Screening ADA | SHIKARI® S-ATV | |
| USTEKINUMAB | TR-Q-USTv1 | Free drug | SHIKARI® Q-UST |
| TR-ATUv1 | Qualitative Screening ADA | SHIKARI® S-ATU |
技术支持：易动力网络
